贿赂 发表于 2025-3-27 00:00:41

Submitted on: 13 October 2021.
Revised on: 28 November 2021.
Accepted on: 22 January 2022.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

观察 发表于 2025-3-27 04:35:14

http://reply.papertrans.cn/1/84/8345/8345-32.png

anaphylaxis 发表于 2025-3-27 07:26:29

http://reply.papertrans.cn/1/84/8345/8345-33.png

prodrome 发表于 2025-3-27 13:21:17

Submitted on: 26 January 2005.
Revised on: 21 May 2005.
Accepted on: 13 July 2005.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Hyperopia 发表于 2025-3-27 14:00:33

http://reply.papertrans.cn/1/84/8345/8345-35.png

Dislocation 发表于 2025-3-27 20:06:07

http://reply.papertrans.cn/1/84/8345/8345-36.png
页: 1 2 3 [4]
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (PHARM